Profile and Organization

Names Figure Facts

Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Our products and services are designed to benefit people and improve their quality of life. At the same time we want to create value through innovation, growth and high earning power.

The Group is committed to the principles of sustainable development and to its role as a socially and ethically responsible corporate citizen. Economy, ecology and social responsibility are corporate policy objectives of equal rank. In fiscal 2010, Bayer employed 111,400 people and had sales of €35.1 billion. Capital expenditures amounted to €1.6 billion, R&D expenses to €3.1 billion.

Organization

Bayer AG defines common values, goals and strategies for the entire Group. The three subgroups and three service companies operate independently, led by the management holding company. The Corporate Center supports the Group Management Board in its task of strategic leadership.

Organization chart with management structure and fields of activity

Download (471 KB)

Business operations are the responsibility of the subgroups:

Bayer HealthCare is among the world’s foremost innovators in the field of pharmaceutical and medical products.
Bayer CropScience, with its highly effective products, pioneering innovations and keen customer focus, holds global leadership positions in crop protection and non-agricultural pest control.
Bayer MaterialScience is a renowned supplier of high-performance materials such as polycarbonates and polyurethanes, and innovative system solutions for a wide range of everyday uses.

Central service functions are combined into three service companies:

Bayer Business Services is the Bayer Group's international competence center for IT-based services.
Bayer Technology Services, the global technological backbone for the Bayer Group and a major innovation driver.
Currenta offers services for the chemical industry including utility supply, waste management, infrastructure, safety, security, analytics and vocational training.

Corporate Governance

Dual governance system with the following governance bodies:

Board of Management:	four members, Chairman: Dr. Marijn Dekkers
Supervisory Board:	20 members, Chairman: Dr. Manfred Schneider

Products

The Bayer Group markets some 5,000 products. Best-sellers include:

in the health care field: Betaferon™/Betaseron™, Yasmin™/YAZ™/Yasminelle™, Kogenate™
in the nutrition field: Confidor™/ Gaucho™/Admire™/Merit™, Flint™/Stratego™/Sphere™/Nativo™
in the field of high-tech materials: Makrolon™, Bayblend™, Desmodur™, Desmophen™

Locations

Bayer is represented around the world by about 300 companies*. Global headquarters are in Leverkusen, Germany

*fully consolidated subsidiaries (as of Dec. 31, 2010)

Workforce

On December 31, 2010, the Bayer Group had 111.400 employees worldwide (2009: 111.000). In Germany we had 36.200 employees, who made up 32,5 percent of the Group workforce.

111.400 employees worldwide (as of December 31, 2010), including:

54.300 in Europe

16.400 in North America

24.600 in Asia/Pacific

16.100 in Latin America/Africa/Middle East

Bayer Stock

included in nearly all the major share indices
traded on all German stock exchanges
dividend per share: EUR 1.50

Bayer Group Key Data

Bayer Group	2009 € million	2010 € million	Change %
Sales	31,168	35,088	12,6
EBITDA	5,815	6,286	8,1
EBITDA before special items	6,472	7,101	9,7
EBIT	3,006	2,730	-9,2
EBIT before special items	3,772	4,452	18,0
Income before income taxes	1,870	1,721	-8,0
Net income	1,359	1,301	-4,3
Earnings per share (in €)	1.70	1.57	-7,6
Gross cash flow	4,658	4,771	2,4
Net cash flow	5,375	5,773	7,4
Capital expenditures as per segment table	1,669	1,621	-2,9
Research and development expenses	2,746	3,053	11,2
Dividend per Bayer AG share (€)	1.40	1.50	7,1

Sales by Segment in Percent, 2010 (2009 in parentheses)

Reconciliation 3.4% (3.7% )

HealthCare 48.2% (51.3%)

Pharmaceuticals 31.1% (33.6%)

Consumer Health 17.1% (17.7%)

CropScience 19.5% (20.9%)

Crop Protection 15.7% (17.4%)

Environmental Science/BioScience 3.8% (3.5%)

MaterialScience 28.9% (24.1%)

Current Financial Reports